These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23891508)
21. The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN. Wang YY; He XY; Cai YY; Wang ZJ; Lu SH Target Oncol; 2011 Sep; 6(3):147-54. PubMed ID: 21611754 [TBL] [Abstract][Full Text] [Related]
22. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients. Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794 [TBL] [Abstract][Full Text] [Related]
23. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC. Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059 [TBL] [Abstract][Full Text] [Related]
24. Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients. Hanagiri T; Takenoyama M; Yoshimatsu T; Hirashima C; Yoshino I; Nakanishi K; Nagashima A; Nomoto K; Yasumoto K Cancer Immunol Immunother; 1996 Oct; 43(2):87-93. PubMed ID: 8954142 [TBL] [Abstract][Full Text] [Related]
25. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy. Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781 [TBL] [Abstract][Full Text] [Related]
26. Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer. Phillips JD; Knab LM; Blatner NR; Haghi L; DeCamp MM; Meyerson SL; Heiferman MJ; Heiferman JR; Gounari F; Bentrem DJ; Khazaie K Cancer Immunol Immunother; 2015 Sep; 64(9):1185-91. PubMed ID: 26047578 [TBL] [Abstract][Full Text] [Related]
27. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes? Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463 [TBL] [Abstract][Full Text] [Related]
28. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients. Li F; Guo Z; Lizée G; Yu H; Wang H; Si T Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790 [TBL] [Abstract][Full Text] [Related]
29. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Erfani N; Mehrabadi SM; Ghayumi MA; Haghshenas MR; Mojtahedi Z; Ghaderi A; Amani D Lung Cancer; 2012 Aug; 77(2):306-11. PubMed ID: 22608141 [TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung. Matsuoka K; Sumitomo S; Misaki N J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581 [TBL] [Abstract][Full Text] [Related]
31. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer. Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195 [TBL] [Abstract][Full Text] [Related]
32. Regulatory T cells in peripheral blood, lymph node, and thyroid tissue in patients with medullary thyroid carcinoma. Müller S; Poehnert D; Müller JA; Scheumann GW; Koch M; Lück R World J Surg; 2010 Jul; 34(7):1481-7. PubMed ID: 20162276 [TBL] [Abstract][Full Text] [Related]
33. CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer. Kashimura S; Saze Z; Terashima M; Soeta N; Ohtani S; Osuka F; Kogure M; Gotoh M Gastric Cancer; 2012 Apr; 15(2):144-53. PubMed ID: 22083420 [TBL] [Abstract][Full Text] [Related]
34. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer. Mony JT; Schuchert MJ Front Immunol; 2018; 9():2298. PubMed ID: 30374348 [No Abstract] [Full Text] [Related]
35. Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients. Kotsakis A; Koinis F; Katsarou A; Gioulbasani M; Aggouraki D; Kentepozidis N; Georgoulias V; Vetsika EK Sci Rep; 2016 Dec; 6():39247. PubMed ID: 27976733 [TBL] [Abstract][Full Text] [Related]
36. Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection. Hoang JK; Patz E; Giroux D; Goldstraw P J Thorac Oncol; 2007 Dec; 2(12):1103-6. PubMed ID: 18090582 [TBL] [Abstract][Full Text] [Related]
37. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer. Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695 [TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division. Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399 [TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer. Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529 [TBL] [Abstract][Full Text] [Related]
40. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]